2026Eki
ILMN Oct 2026 · Sell
Illumina is rated Sell with Fair value of $119.53 compared to $259.19, reflecting -53.9% upside.Latest published research · analyzed 2026-10-22 · current · sources aging
ILMN · Archive
Daha önce yayımlanmış sürümleri, derecelendirmeleri ve fiyat eğilimlerini okuyun. Her satır kendi analiz tarihini belirtir.
USD 259,19
2026May
ILMN May 2026 · Sell
Illumina remains the dominant player in genomic sequencing but is transitioning into a mature compounder phase. Having resolved recent antitrust distractions and returned to profitability in 2025, the company faces normalized mid-single-digit growth, requiring disciplined capital allocation and margin protection against emerging competitors.Historical archived edition · analyzed 2026-05-13